NCT04283643

Brief Summary

Non-invasive brain stimulation techniques, transcranial magnetic stimulation (TMS) and transcranial focused ultrasound (FUS), is be applied to healthy human subjects, acute pain patients, and chronic pain patients to investigate their uses for pain relief.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
149

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

February 3, 2020

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 25, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

February 25, 2020

Status Verified

February 1, 2020

Enrollment Period

2 years

First QC Date

February 3, 2020

Last Update Submit

February 21, 2020

Conditions

Keywords

Transcranial Magnetic StimulationFocused UltrasoundNoninvasive Neuromodulation

Outcome Measures

Primary Outcomes (2)

  • Numeric Pain Rating Scale

    Participants will rate their pain (experimental, acute, chronic) on a 1-10 scale

    immediately after brain stimulation (same day, approximately 5-10 minutes after baseline) as compared to baseline

  • Numeric Pain Rating Scale

    Participants will rate their pain (experimental, acute, chronic) on a 1-10 scale

    immediately after experimental pain measure (up to 15 minutes after baseline) as compared to baseline

Study Arms (3)

Healthy Human Subjects

EXPERIMENTAL

Healthy human subjects will complete study procedures in the research lab at UVA. They will complete pain-related behavioral questionnaires and undergo experimental pain testing for temperature and laser stimuli for real and control conditions of brain stimulation.

Other: Transcranial Focused UltrasoundOther: Transcranial Magnetic Stimulation

Acute Pain Patients

EXPERIMENTAL

Acute Pain Patients will complete study procedures in the hospital or clinic at UVA. They will complete pain-related behavioral questionnaires and undergo experimental pain testing for temperature and laser stimuli for real and control conditions of brain stimulation, as well as rate their ongoing pain.

Other: Transcranial Focused UltrasoundOther: Transcranial Magnetic Stimulation

Chronic Pain Patients

EXPERIMENTAL

Chronic Pain Patients will complete study procedures in the hospital or clinic at UVA. They will complete pain-related behavioral questionnaires and undergo experimental pain testing for temperature and laser stimuli for real and control conditions of brain stimulation, as well as rate their ongoing pain.

Other: Transcranial Focused UltrasoundOther: Transcranial Magnetic Stimulation

Interventions

Non-invasive brain stimulation technique

Acute Pain PatientsChronic Pain PatientsHealthy Human Subjects

Non-invasive brain stimulation technique

Acute Pain PatientsChronic Pain PatientsHealthy Human Subjects

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults between 18 and 80 years of age.
  • Chronic and Acute pain patients: must have an MRI (for ultrasound targeting)

You may not qualify if:

  • Direct report to the study team member
  • History of brain surgery
  • History of seizure
  • Pregnant
  • Have alcohol consumption exceeding 50 drinks/month
  • Have history of opioid abuse (all subjects), or any recent opioid use (healthy controls)
  • Have implant like pacemaker and aneurysm clip
  • Current of psychiatric disease such as anxiety or depression, which is not optimally treated
  • Current infection
  • Current wound on the skin of upper and lower extremities
  • Chronic pain patients: current chronic pain is not optimal controlled by pain medications (i.e. Pain VAS \>5)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Virginia

Charlottesville, Virginia, 22903, United States

RECRUITING

MeSH Terms

Conditions

Acute PainChronic PainPain

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Within subjects design of real and control stimulation, pain measures and behavioral assessments may be compared between healthy subjects and pain groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2020

First Posted

February 25, 2020

Study Start

April 1, 2019

Primary Completion

April 1, 2021

Study Completion

April 1, 2021

Last Updated

February 25, 2020

Record last verified: 2020-02

Locations